Risk stratification for sudden cardiac death

Progress in Biophysics and Molecular Biology

Volumn 98, Issue 2-3, 2008, Pages 340-346

  Sabir, Ian N ^a   Usher Smith, Juliet A ^a   Huang, Christopher L H ^a   Grace, Andrew A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Risk stratification; Sudden cardiac death

Indexed keywords

DEFIBRILLATOR; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; HEART ARRHYTHMIA; HUMAN; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SUDDEN DEATH;

ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC STIMULATION; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGICAL PHENOMENA; HUMANS; RISK FACTORS;

EID: 61849148273     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2009.01.013     Document Type: Review

References (80)

1. Abbushi O. Circadian Variability of QT Dispersion in Healthy Subjects and Patients with Heart Disease (2004), Freie Universität, Berlin
2. Antzelevitch C. Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. Am. J Physiol. Heart. Circ. Physiol. 293 (2007) H2024-H2038
3. Antzelevitch C., Brugada P., Borggrefe M., Brugada J., Brugada R., Corrado D., Gussak I., LeMarec H., Nademanee K., Perez Riera A.R., Shimizu W., Schulze-Bahr E., Tan H., and Wilde A. Brugada syndrome: report of the second consensus conference. Heart Rhythm 2 (2005) 429-440
4. Antzelevitch C., Brugada P., Brugada J., Brugada R., Towbin J.A., and Nademanee K. Brugada syndrome: 1992-2002: a historical perspective. J. Am. Coll. Cardiol. 41 (2003) 1665-1671
5. Antzelevitch C., and Shimizu W. Cellular mechanisms underlying the long QT syndrome. Curr. Opin. Cardiol. 17 (2002) 43-51
6. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., Domanski M., Troutman C., Anderson J., Johnson G., McNulty S.E., Clapp-Channing N., Davidson-Ray L.D., Fraulo E.S., Fishbein D.P., Luceri R.M., and Ip J.H. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med. 352 (2005) 225-237
7. Bigger Jr. J.T. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N. Engl. J. Med. 337 (1997) 1569-1575
8. Bloomfield D.M., Steinman R.C., Namerow P.B., Parides M., Davidenko J., Kaufman E.S., Shinn T., Curtis A., Fontaine J., Holmes D., Russo A., Tang C., and Bigger Jr. J.T. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 110 (2004) 1885-1889
9. Brendorp B., Elming H., Jun L., Kober L., Malik M., Jensen G.B., and Torp-Pedersen C. Qt dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function. Circulation 103 (2001) 831-835
10. Brugada P., and Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J. Am. Coll. Cardiol. 20 (1992) 1391-1396
11. Brugada R., Hong K., Dumaine R., Cordeiro J., Gaita F., Borggrefe M., Menendez T.M., Brugada J., Pollevick G.D., Wolpert C., Burashnikov E., Matsuo K., Wu Y.S., Guerchicoff A., Bianchi F., Giustetto C., Schimpf R., Brugada P., and Antzelevitch C. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 109 (2004) 30-35
12. Buxton A.E., Lee K.L., DiCarlo L., Gold M.R., Greer G.S., Prystowsky E.N., O'Toole M.F., Tang A., Fisher J.D., Coromilas J., Talajic M., and Hafley G. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N. Engl. J. Med. 342 (2000) 1937-1945
13. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., and Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N. Engl. J. Med. 341 (1999) 1882-1890
14. Cygankiewicz I., Zareba W., Vazquez R., Vallverdu M., Gonzalez-Juanatey J.R., Valdes M., Almendral J., Cinca J., Caminal P., and de Luna A.B. Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients. Heart Rhythm 5 (2008) 1095-1102
15. Davey P. QT interval and mortality from coronary artery disease. Prog. Cardiovasc. Dis. 42 (2000) 359-384
16. Doherty J.U., Kienzle M.G., Waxman H.L., Buxton A.E., Marchlinski F.E., and Josephson M.E. Programmed ventricular stimulation at a second right ventricular site: an analysis of 100 patients, with special reference to sensitivity, specificity and characteristics of patients with induced ventricular tachycardia. Am. J. Cardiol. 52 (1983) 1184-1189
17. Eckardt L., Kirchhof P., Schulze-Bahr E., Rolf S., Ribbing M., Loh P., Bruns H.J., Witte A., Milberg P., Borggrefe M., Breithardt G., Wichter T., and Haverkamp W. Electrophysiologic investigation in Brugada syndrome; yield of programmed ventricular stimulation at two ventricular sites with up to three premature beats. Eur. Heart. J. 23 (2002) 1394-1401
18. Editorial. Risk stratification and survival after myocardial infarction. N. Engl. J. Med. 309 (1983) 331-336
19. Elliott P.M., Gimeno Blanes J.R., Mahon N.G., Poloniecki J.D., and McKenna W.J. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 357 (2001) 420-424
20. el-Sherif N., and Turitto G. The long QT syndrome and torsade de pointes. Pacing Clin. Electrophysiol. 22 (1999) 91-110
21. Fananapazir L., Chang A.C., Epstein S.E., and McAreavey D. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation 86 (1992) 730-740
22. Fauchier L., Babuty D., Cosnay P., Poret P., Rouesnel P., and Fauchier J.P. Long-term prognostic value of time domain analysis of signal-averaged electrocardiography in idiopathic dilated cardiomyopathy. Am. J. Cardiol. 85 (2000) 618-623
23. Franz M.R. The electrical restitution curve revisited: steep or flat slope-which is better?. J. Cardiovasc. Electrophysiol. 14 (2003) S140-S147
24. Gang Y., Ono T., Hnatkova K., Hashimoto K., Camm A.J., Pitt B., Poole-Wilson P.A., and Malik M. QT dispersion has no prognostic value in patients with symptomatic heart failure: an ELITE II substudy. Pacing Clin. Electrophysiol. 26 (2003) 394-400
25. Garfinkel A., Kim Y.H., Voroshilovsky O., Qu Z., Kil J.R., Lee M.H., Karagueuzian H.S., Weiss J.N., and Chen P.S. Preventing ventricular fibrillation by flattening cardiac restitution. Proc. Natl. Acad. Sci. USA 97 (2000) 6061-6066
26. Goedel-Meinen L., Hofmann M., Ryba S., and Schomig A. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic dilated cardiomyopathy. Am. J. Cardiol. 87 (2001) 809-812 A9
27. Ghuran A., Reid F., La Rovere M.T., Schmidt G., Bigger Jr. J.T., Camm A.J., Schwartz P.J., and Malik M. Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction substudy). Am. J. Cardiol. 89 (2002) 184-190
28. Gold M.R., Bloomfield D.M., Anderson K.P., El-Sherif N.E., Wilber D.J., Groh W.J., Estes III N.A., Kaufman E.S., Greenberg M.L., and Rosenbaum D.S. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J. Am. Coll. Cardiol. 36 (2000) 2247-2253
29. Gold M.R., Ip J.H., Costantini O., Poole J.E., McNulty S., Mark D.B., Lee K.L., and Bardy G.H. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation 118 (2008) 2022-2028
30. Goldberger J.J., Cain M.E., Hohnloser S.H., Kadish A.H., Knight B.P., Lauer M.S., Maron B.J., Page R.L., Passman R.S., Siscovick D., Siscovick D., Stevenson W.G., and Zipes D.P. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation 118 (2008) 1497-1518
31. Gomes J.A., Cain M.E., Buxton A.E., Josephson M.E., Lee K.L., and Hafley G.E. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation 104 (2001) 436-441
32. Gupta P., Patel C., Patel H., Narayanaswamy S., Malhotra B., Green J.T., and Yan G.X. T(p-e)/QT ratio as an index of arrhythmogenesis. J. Electrocardiol. (2008)
33. Healey J., and Connolly S. Life and death after ICD implantation. N. Engl. J. Med. 359 (2008) 1058-1059
34. Hjalmarson A., Goldstein S., Fagerberg B., Wedel H., Waagstein F., Kjekshus J., Wikstrand J., El Allaf D., Vitovec J., Aldershvile J., Halinen M., Dietz R., Neuhaus K.L., Janosi A., Thorgeirsson G., Dunselman P.H., Gullestad L., Kuch J., Herlitz J., Rickenbacher P., Ball S., Gottlieb S., and Deedwania P. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 283 (2000) 1295-1302
35. Hohnloser S.H., Kuck K.H., Dorian P., Roberts R.S., Hampton J.R., Hatala R., Fain E., Gent M., and Connolly S.J. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N. Engl. J. Med. 351 (2004) 2481-2488. Available from: http://www.cms.hhs.gov/coverage/download/id39-5.pdf
36. Huikuri H.V., Mahaux V., and Bloch-Thomsen P.E. Cardiac arrhythmias and risk stratification after myocardial infarction: results of the CARISMA pilot study. Pacing Clin. Electrophysiol. 26 (2003) 416-419
37. Kadish A., Dyer A., Daubert J.P., Quigg R., Estes N.A., Anderson K.P., Calkins H., Hoch D., Goldberger J., Shalaby A., Sanders W.E., Schaechter A., and Levine J.H. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N. Engl. J. Med. 350 (2004) 2151-2158
38. Kanda M., Shimizu W., Matsuo K., Nagaya N., Taguchi A., Suyama K., Kurita T., Aihara N., and Kamakura S. Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome. J. Am. Coll. Cardiol. 39 (2002) 1799-1805
39. Kanters J.K., Haarmark C., Vedel-Larsen E., Andersen M.P., Graff C., Struijk J.J., Thomsen P.E., Christiansen M., Jensen H.K., and Toft E. T(peak)T(end) interval in long QT syndrome. J. Electrocardiol. (2008)
40. Kleber A.G., and Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol. Rev. 84 (2004) 431-488
41. Koller M.L., Riccio M.L., and Gilmour Jr. R.F. Dynamic restitution of action potential duration during electrical alternans and ventricular fibrillation. Am. J. Physiol. 275 (1998) H1635-H1642
42. Kulakowski P., Counihan P.J., Camm A.J., and McKenna W.J. The value of time and frequency domain, and spectral temporal mapping analysis of the signal-averaged electrocardiogram in identification of patients with hypertrophic cardiomyopathy at increased risk of sudden death. Eur. Heart J. 14 (1993) 941-950
43. Malik M., and Batchvarov V.N. Measurement, interpretation and clinical potential of QT dispersion. J. Am. Coll. Cardiol. 36 (2000) 1749-1766
44. Maron M.S., Olivotto I., Betocchi S., Casey S.A., Lesser J.R., Losi M.A., Cecchi F., and Maron B.J. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N. Engl. J. Med. 348 (2003) 295-303
45. Medicare, 2003. National Coverage Determination: Implantable Automatic Defibrillators.
46. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., and Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N. Engl. J. Med. 335 (1996) 1933-1940
47. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., Daubert J.P., Higgins S.L., Brown M.W., and Andrews M.L. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. 346 (2002) 877-883
48. Narayan S.M. T-wave alternans and the susceptibility to ventricular arrhythmias. J. Am. Coll. Cardiol. 47 (2006) 269-281
49. Nolasco J.B., and Dahlen R.W. A graphic method for the study of alternation in cardiac action potentials. J. Appl. Physiol. 25 (1968) 191-196
50. Okin P.M., Devereux R.B., Howard B.V., Fabsitz R.R., Lee E.T., and Welty T.K. Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. Circulation 101 (2000) 61-66
51. Padmanabhan S., Silvet H., Amin J., and Pai R.G. Prognostic value of QT interval and QT dispersion in patients with left ventricular systolic dysfunction: results from a cohort of 2265 patients with an ejection fraction of < or = 40%. Am. Heart J. 145 (2003) 132-138
52. Papadakis M., Whyte G., and Sharma S. Preparticipation screening for cardiovascular abnormalities in young competitive athletes. BMJ 337 (2008) a1596
53. Perkimki J., Koistinen M.J., Yli-Myry S., and Huikuru H. Measurement of QT dispersion identifies patients at risk. J. Am. Coll. Cardiol. 26 (1995) 174-179
54. Priori S.G., Napolitano C., Gasparini M., Pappone C., Della Bella P., Giordano U., Bloise R., Giustetto C., De Nardis R., Grillo M., Ronchetti E., Faggiano G., and Nastoli J. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 105 (2002) 1342-1347
55. Rosenbaum D.S., Jackson L.E., Smith J.M., Garan H., Ruskin J.N., and Cohen R.J. Electrical alternans and vulnerability to ventricular arrhythmias. N. Engl. J. Med. 330 (1994) 235-241
56. Sakabe K., Ikeda T., Sakata T., Kawase A., Kumagai K., Tezuka N., Takami M., Nakae T., Noro M., Enjoji Y., Sugi K., and Yamaguchi T. Comparison of T-wave alternans and QT interval dispersion to predict ventricular tachyarrhythmia in patients with dilated cardiomyopathy and without antiarrhythmic drugs: a prospective study. Jpn. Heart J. 42 (2001) 451-457
57. Sanz G., Castaner A., Betriu A., Magrina J., Roig E., Coll S., Pare J.C., and Navarro-Lopez F. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N. Engl. J. Med. 306 (1982) 1065-1070
58. Saumarez R.C., Camm A.J., Panagos A., Gill J.S., Stewart J.T., de Belder M.A., Simpson I.A., and McKenna W.J. Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms. Circulation 86 (1992) 467-474
59. Saumarez R.C., and Grace A.A. Paced ventricular electrogram fractionation and sudden death in hypertrophic cardiomyopathy and other non-coronary heart diseases. Cardiovasc. Res. 47 (2000) 11-22
60. Saumarez R.C., Pytkowski M., Sterlinski M., Bourke J.P., Clague J.R., Cobbe S.M., Connelly D.T., Griffith M.J., McKeown P.P., McLeod K., Morgan J.M., Sadoul N., Chojnowska L., Huang C.L., and Grace A.A. Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy. Eur. Heart J. 29 (2008) 1653-1661
61. Saumarez R.C., Pytkowski M., Sterlinski M., Hauer R.N., Derksen R., Lowe M.D., Szwed H., Huang C.L., Ward D.E., Camm A.J., and Grace A.A. Delayed paced ventricular activation in the long QT syndrome is associated with ventricular fibrillation. Heart Rhythm 3 (2006) 771-778
62. Saumarez R.C., Slade A.K., Grace A.A., Sadoul N., Camm A.J., and McKenna W.J. The significance of paced electrogram fractionation in hypertrophic cardiomyopathy. A prospective study. Circulation 91 (1995) 2762-2768
63. Shimizu W., Aiba T., and Kamakura S. Mechanisms of disease: current understanding and future challenges in Brugada syndrome. Nat. Clin. Pract. Cardiovasc. Med. 2 (2005) 408-414
64. Shimizu W., and Antzelevitch C. Cellular and ionic basis for T-wave alternans under long-QT conditions. Circulation 99 (1999) 1499-1507
65. Spielman S.R., Farshidi A., Horowitz L.N., and Josephson M.E. Ventricular fibrillation during programmed ventricular stimulation: incidence and clinical implications. Am. J. Cardiol. 42 (1978) 913-918
66. Spirito P., Bellone P., Harris K.M., Bernabo P., Bruzzi P., and Maron B.J. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N. Engl. J. Med. 342 (2000) 1778-1785
67. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93, 1996, 1043-1065.
68. Turitto G., Ahuja R.K., Bekheit S., Caref E.B., Ibrahim B., and el-Sherif N. Incidence and prediction of induced ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. Am. J. Cardiol. 73 (1994) 770-773
69. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N. Engl. J. Med. 327 (1992) 227-233
70. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N. Engl. J. Med. 321 (1989) 406-412
71. Vandepol C.J., Farshidi A., Spielman S.R., Greenspan A.M., Horowitz L.N., and Josephson M.E. Incidence and clinical significance of induced ventricular tachycardia. Am. J. Cardiol. 45 (1980) 725-731
72. Viskin S. Inducible ventricular fibrillation in the Brugada syndrome: diagnostic and prognostic implications. J. Cardiovasc. Electrophysiol. 14 (2003) 458-460
73. Weiss J.N., Karma A., Shiferaw Y., Chen P.S., Garfinkel A., and Qu Z. From pulsus to pulseless: the saga of cardiac alternans. Circ. Res. 98 (2006) 1244-1253
74. Wellens H.J., Schuilenburg R.M., and Durrer D. Electrical stimulation of the heart in patients with ventricular tachycardia. Circulation 46 (1972) 216-226
75. Whang W., Mittleman M.A., Rich D.Q., Wang P.J., Ruskin J.N., Tofler G.H., Muller J.E., and Albert C.M. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study. Circulation 109 (2004) 1386-1391
76. Yamaguchi M., Shimizu M., Ino H., Terai H., Uchiyama K., Oe K., Mabuchi T., Konno T., Kaneda T., and Mabuchi H. T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity. Clin. Sci. (Lond.) 105 (2003) 671-676
77. Yan G.-X., and Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation 98 (1998) 1928-1936
78. Zabel M., Klingenheben T., Franz M.R., and Hohnloser S.H. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study. Circulation 97 (1998) 2543-2550
79. Zimetbaum P.J., Buxton A.E., Batsford W., Fisher J.D., Hafley G.E., Lee K.L., O'Toole M.F., Page R.L., Reynolds M., and Josephson M.E. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Circulation 110 (2004) 766-769
80. Zipes D.P., and Wellens H.J. Sudden cardiac death. Circulation 98 (1998) 2334-2351